Specifications tableSubject areaCardiologyMore specific subject areaElectrocardiology, computerized electrocardiogram interpretationType of dataTables, figures, and imagesHow data was acquiredReview of health records and automated measurements provided by computerized electrocardiogram interpretation software (MUSE by *GE Healthcare;* Milwaukee, WI)Data formatRaw and analyzed dataParameters for data collectionEvaluated electrocardiograms were paired wide complex tachycardia and baseline electrocardiograms attained within clinical settings throughout the entire Mayo Clinic enterprise between September 2011 and December 2018.Description of data collectionEvaluated electrocardiograms were standard 12-lead recordings obtained from Mayo Clinic\'s centralized electrocardiogram data archives. Wide complex tachycardias were required to fulfill wide complex tachycardia criteria (QRS duration ≥ 120 ms; heart rate ≥ 100 bpm) plus a formal ECG laboratory interpretation of (i) \"ventricular tachycardia,\" (ii) \"supraventricular tachycardia,\" or (iii) \"wide complex tachycardia.\" Baseline electrocardiograms were either the first subsequent electrocardiogram or most proximate that did not fulfill wide complex tachycardia criteria.Data source locationMayo ClinicData accessibilityData is included in this articleRelated research articleA.M. May, C.V. DeSimone, A.H. Kashou, H. Sridhar, D.O. Hodge, R. Carter, G. Lin, S.J. Asirvatham, P.A. Noseworthy, A.J. Deshmukh. The VT Prediction Model: A Simplified Means to Differentiate Wide Complex Tachycardias. Journal of Cardiovascular Electrophysiology. December 2019. [10.1111/jce.14321](https://doi.org/10.1111/jce.14321){#interref0002a}.

Value of the data {#sec0001a}
=================

•Enclosed data summarizes the patient demographics, clinical features, and ECG laboratory interpretation codes of patient cohorts used to derive and validate a novel WCT differentiation method known as the VT Prediction Model. Featured data also describes electrocardiographic characteristics of WCTs accurately and erroneously classified by the VT Prediction Model.•Data would be valuable to researchers wanting to understand the patient demographics, clinical characteristics, and electrocardiographic features of WCT events customarily encountered in general clinical practice.•Data would be of value to researchers aiming to specify clinical and ECG features to be examined in prospective evaluations that compare the diagnostic performance of WCT differentiation algorithms.

1. Data description {#sec0001}
===================

[Table 1](#tbl0001){ref-type="table"} summarizes the clinical and ECG laboratory diagnosis data for the derivation cohort. Heart rhythm or non-heart rhythm cardiologists were responsible for most (85.6%) clinical diagnoses. The ECG laboratory assigned definitive or probable interpretive diagnoses to a sizeable majority (94.8%) of WCTs. A minority of evaluated WCTs (32.1%) were derived from patients who underwent an electrophysiology procedure. A sizeable proportion of evaluated WCTs (38.2%) was derived from patients who possessed an implantable intra-cardiac device (e.g., pacemaker).Table 1Derivation Cohort: clinical and ECG laboratory diagnosis.Table 1SWCT (*n*  = 328)VT (*n*  = 273)P-ValueDiagnosing provider Heart rhythm cardiologists141 (43.0)248 (90.8)Non-heart rhythm cardiologists109 (33.2)17 (6.2)\< 0.0001 Non-cardiologists78 (23.8)8 (2.9)ECG lab interpretation Definite VT10 (3.0)226 (82.8)\< 0.0001 Probable VT16 (4.9)26 (9.5) Definite SWCT265 (80.8)6 (2.2) Probable SWCT16 (4.9)5 (1.8) Undifferentiated21 (6.4)10 (3.7)Time separation between WCT and baseline ECG (hours) Mean (SD)381.7 (2183.2)160.2 (632.4)0.77 Median6.38.1 Q1, Q31.0, 43.11.1, 46.3Time separation between WCT and baseline ECG \< 3 h134 (40.9)111 (40.8)0.04 3 - 24 h88 (26.8)63 (23.1) 24 h - 30 days78 (23.8)87 (319) \> 30 days28 (8.5)12 (4.4)Electrophysiology procedure Yes51 (15.5)142 (52.0)\< 0.0001Implanted Device Yes49 (14.9)181 (66.3)\< 0.0001[^1]

[Table 2](#tbl0002){ref-type="table"} describes the patient characteristics of the derivation cohort. The VT group included more ECG pairs from patients with coronary artery disease, prior myocardial infarction, ischemic cardiomyopathy, non-ischemic cardiomyopathy, active antiarrhythmic drug use, and implanted cardioverter-defibrillator. The supraventricular wide complex tachycardia (SWCT) group comprised more patients having an implanted pacemaker. Baseline ECGs demonstrating ventricular pacing were more prevalent in the ventricular tachycardia (VT) group than the SWCT group. Baseline bundle branch block was more common in the SWCT group than the VT group. No SWCTs (0.0%) demonstrated pre-excitation.Table 2Derivation cohort: patient characteristics.Table 2SWCT (*n*  = 328)VT (*n*  = 273)P-ValueAge (years) Mean (SD)70.6 (14.6)65.8 (13.1)\< 0.0001 Range18.0 - 98.027.0 - 90.0Gender Male212 (64.6)225 (82.4)\< 0.0001 Female116 (35.4)48 (17.6)Clinical Characteristics Coronary artery disease160 (48.8)188 (68.9)\< 0.0001 Prior myocardial infarction93 (28.4)157 (57.5)\< 0.0001 Prior heart surgery123 (37.5)118 (43.2)0.15 Congenital heart disease18 (5.5)19 (7.0)0.45 Anti-arrhythmic drug use52 (15.9)165 (60.4)\< 0.0001 Ischemic cardiomyopathy52 (15.9)138 (50.5)\< 0.0001 Non-ischemic cardiomyopathy77 (23.5)89 (32.6)0.01 AICD22 (6.7)176 (64.5)\< 0.0001 Pacemaker27 (8.2)5 (1.8)0.0005Left ventricular ejection fraction (%) Unknown LVEF14 (4.3)1 (0.4)\< 0.0001 LVEF (\<= 30)66 (20.1)118 (43.2) LVEF (49 - 31)59 (18.0)85 (31.1) LVEF (\>= 50)189 (57.6)69 (25.3)Baseline ECG Baseline bundle branch block217 (66.2)39 (14.3)\< 0.0001 Baseline ventricular pacing19 (5.8)110 (40.3)\< 0.0001SWCT with pre-excitation Yes0 (0.0%)\*\*\*\*\*\*[^2]

[Table 3](#tbl0003){ref-type="table"} summarizes the clinical and ECG laboratory diagnosis data for the validation cohort. Heart rhythm or non-heart rhythm cardiologists were responsible for most (90.5%) clinical diagnoses. Definitive or probable diagnoses were assigned to the vast majority (95.0%) of WCTs interpreted by the ECG laboratory. About one-third (34.4%) of evaluated WCTs were derived from patients who underwent an electrophysiology procedure. A substantial percentage (40.2%) of evaluated WCTs were derived from patients who possessed an implantable intra-cardiac device.Table 3Validation cohort: clinical and ECG laboratory diagnosis.Table 3SWCT (*n*  = 144)VT (*n*  = 97)P-ValueDiagnosing provider Heart rhythm cardiologists59 (41.0)82 (84.5)\< 0.001 Non-heart rhythm cardiologists63 (43.8)14 (14.4) Non-cardiologists22 (15.3)1 (1.0)ECG lab interpretation Definite VT9 (6.2)68 (70.1)\< 0.001 Probable VT1 (0.7)9 (9.3) Definite SWCT87 (60.4)3 (3.1) Probable SWCT41 (28.5)11 (11.3) Undifferentiated6 (4.2)6 (6.2)Time separation between WCT and baseline ECG (hours) Mean (SD)275.9 (1293.8)104.3 (434.8)0.075 Median10.15.1 Q1, Q31.5, 46.60.6, 33.8Time separation between WCT and Baseline ECG \< 3 h47 (32.6)45 (46.4)0.174 3 - 24 h46 (31.9)23 (23.7) 24 h - 30 days46 (31.9)27 (27.8) \> 30 days5 (3.5)2 (2.1)Electrophysiology procedure Yes26 (18.1)57 (58.8)\< 0.001Implanted device Yes27 (18.8)70 (72.2)\< 0.001[^3]

[Table 4](#tbl0004){ref-type="table"} details the clinical characteristics of patients comprising the validation cohort. The VT group included more ECG pairs from patients with coronary artery disease, prior myocardial infarction, ischemic cardiomyopathy, active antiarrhythmic drug use, and implanted cardioverter-defibrillator. The SWCT group comprised more ECG pairs from patients having an implanted pacemaker. Baseline ECGs demonstrating ventricular pacing were more prevalent in the VT group than the SWCT group. Baseline bundle branch block was more common in the SWCT group than the VT group. Four SWCTs (2.8%) demonstrated pre-excitation.Table 4Validation cohort: clinical and ECG laboratory diagnosis.Table 4SWCT (*n* = 144)VT (*n* = 97)P-ValueAge (years) Mean (SD)69.4 (14.8)67.5 (10.8)0.027Gender Male102 (70.8)87 (89.7)\< 0.001 Female42 (29.2)10 (10.3)Clinical Characteristics Coronary artery disease54 (37.5)71 (73.2)\< 0.001 Prior myocardial infarction34 (23.6)67 (69.1)\< 0.001 Prior heart surgery45 (31.2)29 (29.9)0.823 Congenital heart disease5 (3.5)0 (0.0)0.064 Anti-arrhythmic drug use25 (17.4)48 (49.5)\< 0.001 Ischemic cardiomyopathy27 (18.8)63 (64.9)\< 0.001 Non-ischemic cardiomyopathy49 (34.0)24 (24.7)0.124 AICD21 (14.6)70 (72.2)\< 0.001 Pacemaker7 (4.9)0 (0.0)0.028Left ventricular ejection fraction (%) Unknown LVEF7 (4.9)1 (1.0)\< 0.001 LVEF (\<= 30)35 (24.3)45 (46.4) LVEF (49 - 31)27 (18.8)31 (32.0) LVEF (\>= 50)75 (52.1)20 (20.6)Baseline ECG Baseline bundle branch block90 (62.5)17 (17.5)\< 0.001 Baseline ventricular pacing8 (5.6)33 (34.0)\< 0.001SWCT with Pre-excitation Yes4 (2.8)\*\*\*\*\*\*[^4]

[Table 5](#tbl0005){ref-type="table"} summarizes electrocardiographic characteristics of correct and incorrect diagnoses established by the VT Prediction Model for the derivation cohort. According to a 50% VT probability partition to establish VT diagnoses (VT \> = 50.0% and SWCT \< 50.0%), 53 out of 278 (19.1%) clinical VTs were incorrectly branded as SWCT by the VT Prediction Model. In comparison with correctly identified VTs, erroneous classifications of clinical VT as SWCT displayed shorter WCT QRS duration and constrained changes in QRS duration, QRS axis, and T axis between paired baseline and WCT ECGs. According to a 50% VT probability partition to establish VT diagnoses (VT \> = 50.0% and SWCT \< 50.0%), 38 out of 323 (11.8%) clinical SWCTs were erroneously categorized as VT by the VT Prediction Model. In comparison with correctly identified SWCTs, erroneous classifications of clinical SWCT as VT demonstrated more prolonged WCT QRS intervals and larger changes in QRS duration, QRS axis, and T axis between paired baseline and WCT ECGs.Table 5Derivation cohort: correct and erroneous WCT diagnoses.Table 5WCT (*n* = 601)VT (*n* = 273)SWCT (*n* = 328)Erroneous SWCT Prediction (*n* = 53)Correct VT Prediction (*n* = 220)P-valueErroneous VT Prediction (*n* = 38)Correct SWCT Prediction (*n* = 290)P-valueWCT QRS duration (ms)147.7 (19.7)183.9 (30.3)\< 0.0001163.6 (20.1)140.3.6 (15.7)\< 0.0001QRS duration change (ms)24.7 (17.9)51.5 (35.9)\< 0.000141.5 (33.6)13.7 (14.2)\< 0.0001QRS axis change (°)35.2 (36.5)99.0 (54.8)\< 0.000168.7 (56.9)20.1 (23.7)\< 0.0001T axis change (°)50.1 (46.4)101.8 (55.8)\< 0.000192.9 (47.8)34.1 (35.1)\< 0.0001[^5]

[Fig. 1](#fig0001){ref-type="fig"} illustrates the diagnostic performance of the VT Prediction Model for the derivation cohort (AUC 0.924; CI 0.903 -- 0.944).Fig. 1VT prediction model diagnostic performance: derivation cohort.Fig. 1

[Fig. 2](#fig0002){ref-type="fig"} illustrates the diagnostic performance of the VT Prediction Model when implemented on the validation cohort (AUC 0.900; CI 0.862 -- 0.939).Fig. 2VT prediction model diagnostic performance: validation cohort.Fig. 2

[Fig. 3](#fig0003){ref-type="fig"} provides an example of paired VT (A) and baseline (B) ECGs assigned high VT probability (99.0006%) by the VT Prediction Model. WCT QRS duration = 182 ms; QRS duration change = 48 ms; QRS axis change = 134°; T axis change = 93°Fig. 3Appropriate high VT probability assignment.Fig. 3

[Fig. 4](#fig0004){ref-type="fig"} provides an example of paired SWCT (A) and baseline (B) ECGs assigned low VT probability (4.3609%) by the VT Prediction Model. WCT QRS duration = 130 ms; QRS duration change = 46 ms; QRS axis change = 1°; T axis change = 8°Fig. 4Appropriate low VT probability assignment.Fig. 4

[Fig. 5](#fig0005){ref-type="fig"} provides an example of paired SWCT (A) and baseline (B) ECGs assigned low VT probability (6.3613%) by the VT Prediction Model. WCT QRS duration = 120 ms; QRS duration change = 36 ms; QRS axis change = 48°; change T axis change = 13°Fig. 5Appropriate low VT probability assignment.Fig. 5

[Fig. 6](#fig0006){ref-type="fig"} provides an example of paired VT (A) and baseline (B) ECGs assigned low VT probability (9.8704%) by the VT Prediction Model. WCT QRS duration = 126 ms; QRS duration change = 6 ms; QRS axis change = 63°; T axis change = 30°Fig. 6Erroneous low VT probability assignment.Fig. 6

[Fig. 7](#fig0007){ref-type="fig"} provides an example of paired SWCT (A) and baseline (B) ECGs assigned high VT probability (54.0039%) by the VT Prediction Model. WCT QRS duration = 170 ms; QRS duration change = 52 ms; QRS axis change = 3°; T axis change = 89°Fig. 7Erroneous high VT probability assignment.Fig. 7

2. Experimental design, materials, and methods {#sec0002}
==============================================

Our recent publication [@bib0001] describes the derivation and implementation of a new WCT differentiation method that produces explicit VT probability estimations for paired WCT and baseline ECGs. In this report, a logistic regression model (i.e., VT Prediction Model) was derived and tested using two using separate patient cohorts: derivation and validation. First, a derivation cohort of paired WCT and baseline ECGs was evaluated to identify independent predictors to be consolidated into the VT Prediction Model. After that, the VT Prediction Model was trialed against a separate validation cohort of paired WCT and baseline ECGs. The overall diagnostic performance of the VT Prediction Model was appraised according to its agreement with the final clinical diagnosis established by patients\' supervising physicians.

Paired WCT and baseline ECGs were derived from actual clinical settings throughout the entire Mayo Clinic enterprise between September 2011 and December 2018. Evaluated ECGs were standard 12-lead paper recordings (speed: 25 mm/s, voltage calibration: 10 mm/mV) acquired from Mayo Clinic\'s ECG data archives (*GE Healthcare;* Milwaukee, WI).

Included WCTs were required to fulfill WCT criteria (QRS duration ≥ 120 ms and heart rate ≥ 100 bpm) plus an official ECG laboratory interpretation of (1) \"ventricular tachycardia,\" (2) \"supraventricular tachycardia,\" or (3) \"wide complex tachycardia.\" Baseline ECGs were either the first subsequent ECG (i.e., for the derivation cohort) or nearest ECG (i.e., for the validation cohort), not fulfilling WCT criteria.

The derivation cohort encompassed 601 paired WCT (273 VT, 328 SWCT) and baseline ECGs from 421 patients presenting to Mayo Clinic Rochester or Mayo Clinic Health System of South Eastern Minnesota (September 2011 through November 2016). The validation cohort comprised 241 WCT (97 VT, 144 SWCT) and baseline ECG pairs from 177 patients presenting to the whole Mayo Clinic enterprise (January 2018 through December 2018) -- including three large medical centers (Rochester, Minnesota; Jacksonville, Florida; and Phoenix/Scottsdale, Arizona) and auxiliary patient care locations (e.g., community hospitals).

Data relating to clinical diagnosis, ECG laboratory examination, and patient characteristics were discovered from an electronic medical record review. Standard ECG measurements rendered by *GE Healthcare\'s* MUSE ECG interpretation software were acquired from archived ECG recordings. Basic arithmetical computations (QRS axis change, T wave axis change, QRS duration change) were processed using electronic measurements routinely displayed on ECG recordings.

The Mayo Clinic Institutional Review Board approved patient data acquisition and analysis. Similar patient selection processes and data reporting were previously adopted in a separate analysis \[[@bib0002],[@bib0003]\].
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[^1]: Numbers in parentheses are percent (%) of n or standard deviation. SD = standard deviation; SWCT = supraventricular tachycardia; VT = ventricular tachycardia.

[^2]: Numbers in parentheses are percent (%) of n or standard deviation. AICD = automatic implantable cardioverter-defibrillator; LVEF = left ventricular ejection fraction; SD = standard deviation; SWCT = supraventricular tachycardia; VT = ventricular tachycardia.

[^3]: Numbers in parentheses are percent (%) of n or standard deviation. SD = standard deviation; SWCT = supraventricular tachycardia; VT = ventricular tachycardia.

[^4]: Numbers in parentheses are percent (%) of n or standard deviation. AICD = automatic implantable cardioverter-defibrillator; LVEF = left ventricular ejection fraction; SD = standard deviation; SWCT = supraventricular tachycardia; VT = ventricular tachycardia.

[^5]: Displayed numbers represent mean values. Numbers in parentheses are standard deviation. The erroneous VT prediction group comprise clinical SWCTs assigned high VT probability (\>= 50%). The erroneous SWCT prediction group comprise clinical VTs assigned low VT probability (\< 50%). SWCT = supraventricular wide complex tachycardia; VT= ventricular tachycardia; WCT = wide complex tachycardia.
